Breast Cancer Systemic Treatments and Upper Limb Lymphedema: A Risk-Assessment Platform Encompassing Tumor-Specific Pathological Features Reveals the Potential Role of Trastuzumab

Breast cancer related lymphedema (BCRL) is frequent but strategies for an individualized risk assessment are lacking. We aimed to define whether tumor-specific pathological features, coupled with clinical and therapeutic data, could help identify patients at risk. Data from 368 patients with node-po...

Descripción completa

Detalles Bibliográficos
Autores principales: Invernizzi, Marco, Michelotti, Anna, Noale, Marianna, Lopez, Gianluca, Runza, Letterio, Giroda, Massimo, Despini, Luca, Blundo, Concetta, Maggi, Stefania, Gambini, Donatella, Fusco, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406664/
https://www.ncbi.nlm.nih.gov/pubmed/30682851
http://dx.doi.org/10.3390/jcm8020138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406664/
https://www.ncbi.nlm.nih.gov/pubmed/30682851
http://dx.doi.org/10.3390/jcm8020138

Ejemplares similares